Qiong‐Cong Xu

机构：Sun Yat-sen University, The First Affiliated Hospital, Sun Yat-sen University · ORCID：0000-0001-7655-4921

发表论文 42 篇 · 总被引 991 次 · h-index 15

代表论文

• N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma gemcitabine resistance (2024 · Oncogene · 被引 35)
• CSNK2A1 confers gemcitabine resistance to pancreatic ductal adenocarcinoma via inducing autophagy (2024 · Cancer Letters · 被引 23)
• Platelet‐Derived Growth Factor C Facilitates Malignant Behavior of Pancreatic Ductal Adenocarcinoma by Regulating SREBP1 Mediated Lipid Metabolism (2024 · Advanced Science · 被引 15)
• ADAR1 promotes cisplatin resistance in intrahepatic cholangiocarcinoma by regulating BRCA2 expression through A‐to‐I editing manner (2024 · Cell Proliferation · 被引 14)
• Anti-PD-L1 blockade facilitates antitumor effects of radiofrequency ablation by improving tumor immune microenvironment in hepatocellular carcinoma (2024 · APOPTOSIS · 被引 12)
• Auranofin facilitates gemcitabine sensitivity by regulating TXNRD1-related ferroptosis in pancreatic ductal adenocarcinoma (2025 · Cancer Letters · 被引 8)